Effect of recombinant interferon-alpha on streptozotocin-induced chromosome aberrations and sister-chromatid exchanges in hamster cells

Toxicology in Vitro

Volumn 18, Issue 6, 2004, Pages 901-905

  Bolzan A D ^a   Lacunza, E ^a   Bianchi, M S ^a  

^a Instituto Multidisciplinario de Biologia Celular   (Argentina)

Author keywords

ANOVA, Analysis of variance; CAs, chromosomal aberrations; CHO, Chinese hamster ovary; Chromosomal aberrations; RI, replication index; rIFN alpha 2a, recombinant interferon alpha 2a; SCEs, sister chromatid exchanges; STZ, streptozotocin

Indexed keywords

ANTIBIOTIC AGENT; RECOMBINANT ALPHA2A INTERFERON; STREPTOZOCIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROTECTION; CHO CELL; CHROMOSOME ABERRATION; CONTROLLED STUDY; CULTURE MEDIUM; DNA SYNTHESIS INHIBITION; DRUG EFFECT; FEMALE; NONHUMAN; SISTER CHROMATID EXCHANGE; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHROMOSOME ABERRATIONS; CRICETINAE; CRICETULUS; CYCLOPHOSPHAMIDE; DNA; DNA REPAIR; DOXORUBICIN; INTERFERON TYPE I, RECOMBINANT; SISTER CHROMATID EXCHANGE; STREPTOZOCIN; VINCRISTINE;

CRICETINAE; CRICETULUS GRISEUS;

EID: 4744360634     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2004.02.002     Document Type: Article

References (24)

1. Anger B., Porzsolt F., Leichtle R., Heinze B., Bartram C., Heimpel H. A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia. Blut. 58:1989;275-278
2. Arutyunyan R.M., Sarkisyan T.F., Oganesyan G.G., Durnev A.D. Comparative investigation of anticlastogenic effects in cell cultures of healthy donors and patients with nettle-rash. Mutation Research. 320:1994;335-341
3. Bafaloukos D., Pavlidis N., Fountzilas G., Skarlos D., Klouvas G., Makrantonakis P., Giannakakis T., Tsavaris N., Kosmidis P. Recombinant interferon ALFA-2A in combination with carboplatin, vinblastine, and bleomycin in the treatment of advanced malignant melanoma. American Journal of Clinical Oncology. 19:1996;296-300
4. Bolzán A.D., Bianchi M.S. Genotoxicity of streptozotocin. Mutation Research. 512:2002;121-134
5. Bolzán A.D., González M.C., Bianchi M.S. The effect of 1,10-phenanthroline on the chromosome damage and sister-chromatid exchanges induced by streptozotocin in mammalian and insect cells. Mutation Research. 447:2000;221-226
6. Bolzán A.D., Correa M.V., Bianchi M.S. Effect of recombinant interferon alpha on the bleomycin-induced chromosome damage in hamster cells. Mutation Research. 505:2002;43-50
7. Bolzán A.D., Lacunza E., Bianchi M.S. Effect of recombinant interferon alpha on the streptonigrin-induced chromosome aberrations and sister-chromatid exchanges in hamster cells. Mutation Research. 522:2003;127-134
8. Fisher R.A., Yates F. Statistical Tables for Biological, Agricultural and Medical Research. fifth ed.:1957;Oliver and Boyd, London. p. 61
9. Herr R.R., Jahnke A.D., Argoudelis A.D. The structure of streptozotocin. Journal of the American Chemical Society. 89:1967;4808-4809
10. Hrelia P., Morotti M., Vigagni F., Maffei F., Paolini M., Mesirca R., Cantelli-Forti G. The modulating activity of interferon on benzo(a)pyrene bioactivation and clastogenesis in mice. Pharmacology and Toxicology. 74:1994;249-254
11. Ivett J.L., Tice R.R. Average generation time: a new method of analysis and quantitation of cellular proliferation kinetics. Environmental Mutagenesis. 4:1982;358
12. Lazutka J.R. Genetic toxicity of cytokines. Mutation Research. 361:1996;95-105
13. Lazutka J.R., Slapsyte G., Jarmalaite S., Lekevicius R.K. In vitro interaction between two antineoplastic drugs-phorpurinum and interferon alpha 2. Cancer Letters. 47:1989;53-56
14. Makedonov G.P., Chekova V.V., Iakubovskaia E.L., Zasukhina G.D. Modification of DNA repair by human interferons. Acta Biologica Hungarian. 41:1990;187-197
15. Makedonov G.P., Alekhina N.I., Tskhovrebova L.V., Zasukhina G.D. A comparison of the efficacy of the anticlastogenic action of interferon and of the radiation-adaptive response. Radiobiologiia. 33:1993;259-264
16. Marmont A.M., Sessarego M. Chronic clonal myeloproliferative disease associated with a t(5;21) translocation. Complete but transient hematologic and cytogenetic remission induced by interferon-alpha. Leukemia. 9:1995;977-980
17. Perry P.E., Wolff P. New Giemsa method for differential staining of sister chromatids. Nature. 251:1974;156-158
18. Sarkisian T.F., Movsesian E.S., Arutiunian R.M., Zasukhina G.D. Effect of interferon on the number of cytogenetic disorders occurring in human cultured lymphocytes treated with thio-TEPA and fotrin. Tsitologiia. 30:1988;1491-1494
19. ′- nitro-N-nitrosoguanidine. Molecular Genetics in Mikrobiology and Virusology. 4:1987;39-43
20. Sirota N.P., Bezlepkin V.G., Kuznetsova E.A., Lomayeva M.G., Milonova I.N., Ravin V.K., Gaziev A.J., Bradbury R.J. Modifying effect in vivo of interferon alpha on induction and repair of lesions of DNA of lymphoid cells of gamma-irradiated mice. Radiation Research. 146:1996;100-105
21. Suzuki N. Effects of human interferon-alpha on UV-induced DNA-repair synthesis and cell killing. Mutation Research. 175:1986;189-193
22. Talpaz M., Kantarjian H.M., McCredie K.B., Trujillo J., Keating M.J., Gutterman J. Therapy of chronic myelogenous leukemia. Cancer. 59:1987;664-667
23. Walter M.R., Bordens R., Nagabhushan T.L., Williams B.R., Herberman R.B., Dinarello C.A., Borden E.C., Trotta P.P., Pestka S., Pfeffer L.M. Review of recent developments in the molecular characterization of recombinant alfa interferons on the 40th anniversary of the discovery of interferon. Cancer Biotherapy and Radiopharmacology. 13:1998;143-154
24. Wang P.L., Cong S.Y., Dong X.Y., Chen Z.C., Ma C.P. A genetic study of human interferon-alpha-induced repair of DNA damage in hepatitis B patients. Mutation Research. 262:1991;125-138